Skip to content

Emergent BioSolutions Inc Sustainability Reports

Emergent BioSolutions Inc. is a global life sciences company that develops and manufactures specialty products, vaccines, and antibody therapeutics designed to address public health threats and medical countermeasures. Its commercial offerings include products for opioid overdose reversal and biodefense protections against pathogens such as anthrax and smallpox.

Sector: Manufacturing

Country: United States

Exchange: New York Stock Exchange

ISIN: US29089Q1058

22 reports from 2008 to 2025